Controlling Inflammation & Connective Tissue If you accept that we are in the order of 100 trillion cells. That each one of those cells relies on up to 90 nutrients, fresh air and potable water for survival. That cellular malnutrition is the major cause of illness and death. That optimizing cellular nutrition guarantees better health. Then will you appreciate what is to follow. If you do not accept the foregoing stop reading now! The following of necessity, deals with some of the processes of inflammation. However, some relatively new anti-inflammatory and naturally derived substances are changing the way we have regarded inflammation in the past. DEFINITION Immune Response: Occurs when Cells of the Immune System are activated in response to Antigens liberated during either the Acute or Chronic stages of Inflammation. This can be beneficial when Antigens are neutralized (i.e. phagocytosed). This can be detrimental if it leads to Chronic Inflammation without the resolution of the underlying cause of Inflammation. Chronic Inflammation: Involves the release of Interleukins 1,2 and 3; Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF); Tumour Necrosis Factor Alpha; Interferon's and Platelet-Derived Growth Factor. In the past, control of inflammation in body
organ/tissue has relied mostly on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs),
a large group of pharmaceutical Drugs that inhibit inflammation by inhibiting
the endogenous enzymes that catalyse the production of prostaglandins, which
are are a group of endogenous fatty acids normally manufactured within the body
and very rarely obtained via the diet. Another unusual feature of prostaglandins is
that the same prostaglandins function differently in different tissues. Some
prostaglandins are stronger in their function than others. We need a ratio of 2 parts omega-6 to one part omega-3 (2:1) for anti-inflammatory control. Most people in our society have 20-50 to 1 if they are eating some fish or flax seed. Thus we are a society riddled with inflammation. Worse; elevated levels of PGE2 interferes with the formation of bones and increases bone resorption rate. However, we know that
optimally low levels of PGE2, on the other hand, stimulate bone
formation, and are therefore a double edged sword. NEWS Flash BMJ. 2011 Jan 11;342:c7086. doi: 10.1136/bmj.c7086. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P. Institute of Social and Preventive Medicine, University of Bern, Switzerland. Comment in: Abstract OBJECTIVE: To analyse the available evidence on cardiovascular safety of non-steroidal anti-inflammatory drugs. DESIGN: Network meta-analysis. DATA SOURCES: Bibliographic databases, conference proceedings, study registers, the Food and Drug Administration website, reference lists of relevant articles, and reports citing relevant articles through the Science Citation Index (last update July 2009). Manufacturers of celecoxib and lumiracoxib provided additional data. STUDY SELECTION: All large scale randomised controlled trials comparing any non-steroidal anti-inflammatory drug with other non-steroidal anti-inflammatory drugs or placebo. Two investigators independently assessed eligibility. DATA EXTRACTION: The primary outcome was myocardial infarction. Secondary outcomes included stroke, death from cardiovascular disease, and death from any cause. Two investigators independently extracted data. DATA SYNTHESIS: 31 trials in 116 429 patients with more than 115 000 patient years of follow-up were included. Patients were allocated to naproxen, ibuprofen, diclofenac, celecoxib, etoricoxib, rofecoxib, lumiracoxib, or placebo. Compared with placebo, rofecoxib was associated with the highest risk of myocardial infarction (rate ratio 2.12, 95% credibility interval 1.26 to 3.56), followed by lumiracoxib (2.00, 0.71 to 6.21). Ibuprofen was associated with the highest risk of stroke (3.36, 1.00 to 11.6), followed by diclofenac (2.86, 1.09 to 8.36). Etoricoxib (4.07, 1.23 to 15.7) and diclofenac (3.98, 1.48 to 12.7) were associated with the highest risk of cardiovascular death. CONCLUSIONS: Although uncertainty remains, little evidence exists to suggest that any of the investigated drugs are safe in cardiovascular terms. Naproxen seemed least harmful. Cardiovascular risk needs to be taken into account when prescribing any non-steroidal anti-inflammatory drug. PMID: 21224324 [PubMed - indexed for MEDLINE]PMCID: PMC3019238Free PMC Article COMMENT: and you can see TV advertisements every night claiming that Nurofen is kind to the stomach and knows when to leave the body, or words to that effect, and they promote these dangerous drugs for infants and children.
ProResolvin TO THE RESCUE. The solvent control was 5µL H20. (23187) The final result demonstrated that ProResolvin was up to a massive 32 times the anti-inflammatory action of the other substances tested. Hereunder is the Table of comparisons.
Understanding that these statistics may mean little or nothing to the non-mathematical, what is interesting if not a revelation, is the fact that Aspirin obviously inhibits the conversion of PGE2 thus exhibiting its anti-inflammatory action. In contrast the Chondroitin's and Cartilage which contains Chondroitin exert a different action and therefore must act through a pathway other than the synthesis of PGE2 from PGH2 . Dr Flowers stated: "These results show that these products (Chondroitin’s & Cartilage), although successful (in clinical trials) in the treatment of inflammatory processes, must act through a pathway other than the synthesis of PGE2 from PGH2." ProResolvin is extracted from the tracheal cartilage of bovine calf less than 18 months days old. Then through its unique production method as never before, the *Glycosaminoglycans are extracted in their entirety. *Glycosaminoglycans are a group of polysaccharides that are usually comprised of two repeating sugar units, one of which is a hexosamine (an amino sugar - often glucosamine or galactosamine) bound to sulphur. Most people are not aware of the very
effective anti-inflammatory role of glycosaminoglycans, which include but are
not confined to: Therefore ProResolvin may be indicated in all of the following:
As modern research methods increase in sophistication, Inflammation has been tentatively linked as an underlying cause of various ailments that were previously believed to be unrelated to Inflammation including: Aging Process • The recommended dosage of
ProResolvin is 10ml once daily from a spoon, in water, milk, juice or
food, however, this can be safely increased to twice daily initially for maximum
effect The price per 500ml bottle is $70.00 including pack & post We welcome distributors and especially worldwide. We are proud to be a major distributor.
Proceeds to medical research and health promotion. Order. proresolvinfirst@gmail.com Copyright © (2006) Australian Institute of Biological Medicine (non-profit)
|
|
|